Showing 4,401 - 4,420 results of 19,871 for search '"*** (novel)"', query time: 0.10s Refine Results
  1. 4401
  2. 4402
  3. 4403

    A novel signal detection algorithm of multiple-input multiple-output Vertical-Bell Laboratories Layered Space-Time for underwater acoustic networks based on the improved minimum mean square error by Gaoli Zhao, Jianping Wang, Junping Song, Wei Chen

    Published 2020-12-01
    “…This article proposes a novel signal detection algorithm of multiple-input multiple-output Vertical-Bell Laboratories Layered Space-Time. …”
    Get full text
    Article
  4. 4404

    Generation and characterization of novel induced pluripotent stem cell (iPSC) lines derived from three symptomatic carriers of a pathogenic MYH11 variant and two non-carrier relatives by Aria Atash, Maarten Jan Cramer, Barend Mees, Pieter A. Doevendans, Joost P.G. Sluijter, Francesca Stillitano

    Published 2025-02-01
    “…A novel pathogenic variant in the MYH11 gene (c.4559+1G>A) leading to exon 32 skipping, is a rare cause of familial aortic aneurysms and dissections (fTAAD). …”
    Get full text
    Article
  5. 4405

    Synthesis and Anti-inflammatory Activity of Some Novel 3-(6-Substituted-1, 3-benzothiazole-2-yl)-2-[{(4-substituted phenyl) amino} methyl] quinazolines-4 (3H)-ones by Manish Srivastav, MD. Salahuddin, S. M. Shantakumar

    Published 2009-01-01
    “…A series of novel 3-(6-substituted-1, 3-benzothiazole-2-yl)-2-[{(4-substituted phenyl) amino} methyl] quinazolines-4(3H)-ones were synthesized by treating 2-(chloromethyl)-3-(6-substituted-1, 3-benzothiazole-2-yl) quinazoline-4-(3H)-one (IIa-d) with various substituted amine. …”
    Get full text
    Article
  6. 4406
  7. 4407
  8. 4408

    A novel ultra-high temperature ceramic composite coating prepared by high-speed laser cladding and pack cementation on Ta–W alloys for higher plasma ablation resistance above 2300 °C by Youjiang Zhang, Qiyao Deng, Yang Li, Pengfei He, Chuan Sun, Wengang Bu, Yue Xing, Yujun Cai, Xiubing Liang

    Published 2025-01-01
    “…To improve the high-temperature ablation resistance properties of Ta(W) refractory alloys, a novel ultra-high-temperature ceramic (UHTC) composite coating was prepared by combining the technological advantages of high-speed laser cladding (HSLC) and pack cementation (PC). …”
    Get full text
    Article
  9. 4409

    Novel laparoscopic “lateral three-port technique” of extended totally extra peritoneal approach for ventral hernias: Short-term results and technical aspects of 100 consecutive cases from a single center by K. Ganesh Shenoy, Marina Thomas, Ramesh B S, Amol Siddalingappa Jeur, Nawab Jan

    Published 2024-07-01
    “…In this article, we present the technical aspects to perform this procedure by using novel lateral three ports and the short-term results of our experience in this subset of patients. …”
    Get full text
    Article
  10. 4410
  11. 4411
  12. 4412
  13. 4413

    Case report: A novel 11-bp deletion in exon 11 causing a frameshift in the C-terminal of the ALAS2 gene leading to X-linked sideroblastic anemia—a family study by Salam Al kindi, Salam Al kindi, Altaf Al-Mamari, Shoaib Al-Zadjali, Mohamed Al-Rawahi, Ali Al Madhani, Anil V. Pathare

    Published 2025-02-01
    “…It is due to mutations of the erythroid-specific enzyme ALAS2, the first enzyme of the heme biosynthetic pathway. Herein, we report a novel 11-bp deletion in exon 11 leading to a frameshift in the C-terminal region of the ALAS2 gene with a non-functional longer polypeptide of 614 amino acids leading to a loss-of-function mutation manifested as an X-linked sideroblastic anemia phenotype. …”
    Get full text
    Article
  14. 4414
  15. 4415

    Resection and Resolution of Bone Marrow Lesions Associated with an Improvement of Pain after Total Knee Replacement: A Novel Case Study Using a 3-Tesla Metal Artefact Reduction MRI Sequence by Thomas Kurien, Robert Kerslake, Brett Haywood, Richard G. Pearson, Brigitte E. Scammell

    Published 2016-01-01
    “…We present our case report using a novel metal artefact reduction magnetic resonance imaging (MRI) sequence to observe resolution of subchondral bone marrow lesions (BMLs), which are strongly associated with pain, in a patient after total knee replacement surgery. …”
    Get full text
    Article
  16. 4416

    A novel surgical technique for cranial cruciate ligament repair in dogs using autologous lateral digital extensor muscle tendon graft combined with platelet-rich plasma: A preliminary experimental study by Mousa H. Daradka, Mays A. Malkawi, Zuhair Banni Ismail1, Hanan M. Hammouri, Mahmoud A. Abu-Abeeleh, Saba A. Rihani

    Published 2025-01-01
    “…PRP-treated dogs exhibited faster recovery and enhanced tissue regeneration, with reduced inflammation and improved graft-bone attachment. Conclusion: This novel surgical approach demonstrates significant potential for improving outcomes in CrCL repair by combining autologous tendon grafting with PRP. …”
    Get full text
    Article
  17. 4417

    Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study by Itsukaichi A, Yoshikawa F, Fuchigami A, Iwata Y, Sato G, Miyagi M, Hirose T, Uchino H

    Published 2025-01-01
    “…Atsushi Itsukaichi,* Fukumi Yoshikawa,* Ayako Fuchigami, Yoko Iwata, Genki Sato, Masahiko Miyagi, Takahisa Hirose, Hiroshi Uchino Department of Diabetes, Metabolism and Endocrinology, Toho University Graduate School of Medicine, Tokyo, Japan*These authors contributed equally to this workCorrespondence: Hiroshi Uchino, Department of Diabetes, Metabolism, and Endocrinology, Toho University Graduate School of Medicine, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan, Tel +81-3-3762-4151, Fax +81-3-3765-6488, Email h.uchino@med.toho-u.ac.jpPurpose: Imeglimin is a novel oral antidiabetic agent that improves glucose tolerance. …”
    Get full text
    Article
  18. 4418

    Case report: A novel de novo germline loss-of-function mutation in the STAT1 transactivation domain in two Chinese siblings, with the elder sibling presenting with multifocal Bacillus Calmette–Guerin osteomyelitis by Qin Ying Lim, Qin Ying Lim, Daniel Leung, Crystal K. Lam, Xingtian Yang, Kai N. Cheong, Kai N. Cheong, Andrew K. H. Yik, Jing Yang, Koon-Wing Chan, Pamela P. W. Lee, Pamela P. W. Lee, Pamela P. W. Lee, Pamela P. W. Lee, Miyuki Tsumura, Elaine Y. L. Au, Jaime S. Rosa Duque, Jaime S. Rosa Duque, Jaime S. Rosa Duque, Satoshi Okada, Yu Lung Lau, Yu Lung Lau, Yu Lung Lau

    Published 2025-01-01
    “…Individuals with autosomal dominant STAT1 deficiency are more susceptible to intracellular bacteria, the hallmark of which is Mendelian susceptibility to mycobacterial diseases (MSMDs) that are associated with increased risks of invasive disease by weakly virulent mycobacteria. We report a novel de novo heterozygous missense mutation in exon 23 of the STAT1 gene (NM_007315.4):c.2129C>T(p.Ser710Phe) (S710F), located in the transactivation domain (TAD) for two Chinese siblings, whereby the index patient presented with multifocal osteomyelitis after Bacillus Calmette–Guerin (BCG) vaccine, while the younger sibling was spared the infection, as BCG vaccination was withheld at birth. …”
    Get full text
    Article
  19. 4419

    The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells by Chien-Ting Lin, Shang-Ju Wu, Cheng Hao Liao, Reyhung Roc Weng, Chun-Ming Lin

    Published 2025-12-01
    “…These findings support further development of eCD16A/anti-CD3-BFP as a novel anti-cancer therapeutic to stimulate both innate and adaptive immunity.…”
    Get full text
    Article
  20. 4420

    Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial by Jiangtao Bai, Tetsuya Asakawa, Wenfang Yuan, Yuanlong Lin, Hao Ju, Dandan Xu, Mingming Yang, Shuo Li, Guanguan Li, Deyin Guo, Hongzhou Lu, Xumu Zhang

    Published 2025-01-01
    “…These preliminary data on the efficacy and safety provide useful information and a working basis for further verification and development of SHEN26 as a novel oral small-molecule antiviral drug for treating COVID-19.…”
    Get full text
    Article